Merck & Co. said on Sunday it will buy San Diego’s Prometheus Biosciences for about $10.8 billion, in an effort to build up its presence in immunology.
Merck & Co. said on Sunday it will buy San Diego’s Prometheus Biosciences for about $10.8 billion, in an effort to build up its presence in immunology.
